Coronavirus on Trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      NATIONAL Institute of Allergy & Infectious Diseases (U.S.) ; UNITED States. Food & Drug Administration
    • Abstract:
      The article offers information on a randomized, controlled clinical trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), to evaluate the safety and efficacy of remdesivir in Covid-19 patients. Topics covered include the symptoms of Covid-19, and the lack of specific therapeutics approved by the U.S. Food and Drug Administration to treat people with this infection. Also mentioned are ongoing remdesivir clinical trials in China.